Miconazole Nitrate Microparticles in Lidocaine Loaded Films as a Treatment for Oropharyngeal Candidiasis

被引:6
|
作者
Tejada, Guillermo [1 ]
Calvo, Natalia L. [2 ,3 ]
Morri, Mauro [4 ]
Sortino, Maximiliano [5 ,6 ]
Lamas, Celina [2 ,7 ]
Alvarez, Vera A. [1 ]
Leonardi, Dario [2 ,7 ]
机构
[1] Inst Invest Ciencia & Tecnol Mat, Grp Mat Comp Termoplast, Av Colon 10850, RA-7600 Mar Del Plata, Argentina
[2] Inst Quim Rosario, Suipacha 570, RA-2000 Rosario, Argentina
[3] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Quim Organ, Area Anal Medicamentos, Suipacha 570, RA-2000 Rosario, Argentina
[4] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Planta Piloto Prod Medicamentos, Suipacha 570, RA-2000 Rosario, Argentina
[5] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Quim Organ, Area Farmacognosia,Ctr Referencia Micol, Suipacha 570, RA-2000 Rosario, Argentina
[6] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Quim Organ, Area Farmacognosia, Suipacha 570, RA-2000 Rosario, Argentina
[7] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Farm, Area Tecn Farmaceut, Suipacha 570, RA-2000 Rosario, Argentina
关键词
oropharyngeal candidiasis; miconazole nitrate; lidocaine; polymeric microparticles; polymeric films; FORMULATION; SOLUBILITY; DELIVERY; CHITOSAN; MATRICES; ALGINATE;
D O I
10.3390/ma16093586
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Oral candidiasis is an opportunistic infection that affects mainly individuals with weakened immune system. Devices used in the oral area to treat this condition include buccal films, which present advantages over both oral tablets and gels. Since candidiasis causes pain, burning, and itching, the purpose of this work was to develop buccal films loaded with both lidocaine (anesthetic) and miconazole nitrate (MN, antifungal) to treat this pathology topically. MN was loaded in microparticles based on different natural polymers, and then, these microparticles were loaded in hydroxypropyl methylcellulose-gelatin-based films containing lidocaine. All developed films showed adequate adhesiveness and thickness. DSC and XRD tests suggested that the drugs were in an amorphous state in the therapeutic systems. Microparticles based on chitosan-alginate showed the highest MN encapsulation. Among the films, those containing the mentioned microparticles presented the highest tensile strength and the lowest elongation at break, possibly due to the strong interactions between both polymers. These films allowed a fast release of lidocaine and a controlled release of MN. Due to the latter, these systems showed antifungal activity for 24 h. Therefore, the treatment of oropharyngeal candidiasis with these films could reduce the number of daily applications with respect to conventional treatments.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] TREATMENT FOR OROPHARYNGEAL CANDIDIASIS
    FASCIANA, GS
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1984, 108 (03): : 300 - &
  • [22] TREATMENT OF VAGINAL CANDIDIASIS WITH FENTICONAZOLE AND MICONAZOLE
    GASTALDI, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 38 (03): : 489 - 493
  • [23] Development of synergistic antifungal in situ gel of miconazole nitrate loaded microemulsion as a novel approach to treat vaginal candidiasis
    Alwan, Omar M.
    Jaafar, Iman S.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Efficacy and tolerability of miconazole nitrate ovules in pregnants with vaginal candidiasis
    Uysal, Ahmet
    Taner, Cuneyt Eftal
    Mun, Semih
    Oztekin, Murat
    HEALTHMED, 2012, 6 (08): : 2616 - 2619
  • [25] MICONAZOLE NITRATE IN TREATMENT OF DERMATOMYCOSES
    DEGREEF, H
    VERHOEVE, L
    VANCUTSEM, J
    DERMATOLOGICA, 1975, 150 (02): : 103 - 110
  • [26] Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections
    Amaral, Andre Correa
    Saavedra, Pedro H., V
    Oliveira Souza, Ana Camila
    de Melo, Maryanne Trafani
    Tedesco, Antonio Claudio
    Morais, Paulo Cesar
    Soares Felipe, Maria Sueli
    Bocca, Anamelia Lorenzetti
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2019, 174 : 409 - 415
  • [27] TREATMENT FOR OROPHARYNGEAL CANDIDIASIS - COMMENT
    MITCHELL, EW
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1984, 108 (03): : 302 - 302
  • [28] Treatment strategies for oropharyngeal candidiasis
    Laudenbach, Joel M.
    Epstein, Joel B.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (09) : 1413 - 1421
  • [29] TREATMENT AND PREVENTION OF OROPHARYNGEAL CANDIDIASIS
    QUINTILIANI, R
    OWENS, NJ
    QUERCIA, RA
    KLIMEK, JJ
    NIGHTINGALE, CH
    AMERICAN JOURNAL OF MEDICINE, 1984, 77 (4D): : 44 - 48
  • [30] Caspofungin in the treatment of oropharyngeal candidiasis
    Garbino, J
    Lew, D
    Hirschel, B
    Rohner, P
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (02) : 143 - 144